Clinical Trial Update: Nudge Strategies for DPYD Testing in Patients With Gastrointestinal Cancers Treated With Fluoropyrimidines [NA]

View source ↗

Summary

A completed clinical trial evaluated nudge strategies to increase DPYD testing before fluoropyrimidine therapy in patients with gastrointestinal cancer. The stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dihydropyrimidine Dehydrogenase Deficiency
• Gastrointestinal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Capecitabine (capecitabine)

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: DPYD Gene Mutation, Gastrointestinal Cancer | NA | Status: COMPLETED